Results show that people on Trikafta® enrolled in the six-week study were able to safely stop taking one of the two common CF medications without negatively affecting their health.
Site Search
Showing 1 - 4 of 4 results
News
|
|
4 min read
Bill will jump-start rebuilding of the antibiotics pipeline that is vital to stave off a looming pandemic.
News
|
|
3 min read
The cystic fibrosis care model is evolving to support people living longer with CF and their increasingly diverse health needs. Catalyzed by the approval of Trikafta® and the COVID-19 pandemic, this adaptive and personalized care model encompasses novel ways to connect clinicians and patients.
News
|
|
4 min read
Vertex’s copay assistance changes add an undue burden for people living with an already expensive, challenging lifelong disease.
News
|
|
3 min read